跳转至内容
Merck
CN

20362

Supelco

ORBO Carboxen-564 管

W,F,F separators, O.D. × L 6 mm × 75 mm, pkg of 25 ea, for analyte group Vinyl acetate

别名:

ORBO-92 160/80mg,每包 25 支

登录查看公司和协议定价

关于此项目

EC 号:
UNSPSC代码:
47131900
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

物料

W,F,F separators

质量水平

Agency

NIOSH 1453
OSHA 51

产品线

ORBO

组成

Bed A, 160 mg
Bed B, 80 mg

包装

pkg of 25 ea

制造商/商品名称

ORBO 92

技术

active air sampling: suitable

外径 × 长度

6 mm × 75 mm

基质

Carboxen® 564 Carbon Molecular Sieve (CMS)

应用

air monitoring
environmental
industrial hygiene

相容性

for analyte group Vinyl acetate

正在寻找类似产品? 访问 产品对比指南

一般描述

  • ORBO 92 Carboxen® 564 (20/45), 160/80 mg solvent desorption tube is designed for gas and vapor sampling.
  • It contains two beds of the same selective adsorbent separated by glass wool or foam.
  • Dual-layer or two-bed construction of the tube allows for any sample breakthrough to be captured in the smaller back-up bed.

法律信息

Carboxen is a registered trademark of Merck KGaA, Darmstadt, Germany
ORBO is a trademark of Sigma-Aldrich Co. LLC

储存分类代码

11 - Combustible Solids

WGK

nwg

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

H Stalsberg et al.
Virchows Archiv. A, Pathological anatomy and histopathology, 414(5), 415-422 (1989-01-01)
The autopsies of 12 victims from two snow avalanches in North-Norway are reported. Supportive evidence from non-autopsied and surviving victims is included. Consistent autopsy findings were prominent lung oedema, moderate cerebral oedema, extreme contraction of the left ventricle, petechiae in
A Orbo et al.
International journal of oncology, 5(3), 619-625 (1994-09-01)
About 50% of the cases with invasive carcinoma of the uterine cervix occurs before menopause. Cyclic changes of sex steroids may therefore interfere with the ratio between extracellular levels of cGMP and cAMP (cGMP(ex)/cAMP(ex)). This ratio has been proposed as
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine
Anne Beate Vereide et al.
Gynecologic oncology, 97(3), 740-750 (2005-05-12)
The aim of the study was to investigate apoptosis as a growth regulatory mechanism of gestagen in endometrial precancers and to compare differences in the apoptotic cascade after high and low dose gestagen regimens. Pre- and post-treatment paraffin-embedded endometrial hyperplasia
Anne Ørbo et al.
Anticancer research, 35(12), 6401-6409 (2015-12-08)
To investigate if a levonorgestrel-impregnated intrauterine system (LNG-IUS) was more efficient compared to oral progestin in the clearance of the paired box 2 gene (PAX2) - and phosphatase and tensin homolog (PTEN)-null endometrial glands and assess the significance of PAX2-

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持